Odyssey Therapeutics Inc. (ODTX) Live Share Price, Invest From India

Odyssey Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$17.95
Day's Price Range
$19.49
$19.07
5.87%
Downside
2.20%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$19.07
100.00%
Downside
-100.00%
Upside

Odyssey Therapeutics Inc. share price movements today

Previous Close: $18.48
Open: $18.77
Volume: 456.5K
Day's Low - High: $17.95 - $19.49

Odyssey Therapeutics Inc. Historical Returns

1 Month Return: + 12.57 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Odyssey Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Odyssey Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$873.7M

EPS (TTM)

-3.56

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-85.50%

Odyssey Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Odyssey Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Odyssey Therapeutics Inc.	NA	$873.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Indian Investors' Interest in Odyssey Therapeutics Inc. Stock

Search interest for Odyssey Therapeutics Inc. Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:-54% versus previous 30 day period

Odyssey Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024
Total Revenue	1
Gross Profit	-
Operating Income	-37
EBITDA	-
Interest Expense	0
Depreciation	1
Income Before Tax	-35
Income Tax Expense	-
Net Income	-35
Net Profit Margin	-2047.41%

Odyssey Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	1	4	2
Gross Profit	-	-	-	-
Operating Income	-122	-133	-135	-161
EBITDA	-	-	-	-
Interest Expense	0	0	0	0
Depreciation	2	4	5	4
Income Before Tax	-124	-125	-128	-149
Income Tax Expense	-	-	-	-
Net Income	-124	-125	-129	-148
Net Profit Margin	0.00%	-12144.46%	-2891.79%	-4994.86%

Odyssey Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-125	-129	-148
Operating Cash Flow	-112	-117	-129
Investing Cash Flow	-	-	-
Financing Cash Flow	92	26	215
Change in Cash	-185	6	-17

Insights on Odyssey Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ODTX stock has moved up by 12.8%

About Odyssey Therapeutics Inc.

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor"associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.

Organisation	Odyssey Therapeutics Inc.
Headquarters	51 Sleeper Street, Boston, MA, United States, 02210
Industry	Biotechnology
CEO	Dr. Gary D. Glick Ph.D.
E-voting on shares	Click here to vote

Key Management of Odyssey Therapeutics Inc.

Name	Title
Mr. Jason Haas M.B.A.	Chief Financial Officer
Mr. Collin Todd	Senior Vice President of Strategy & Business Development
Dr. Felix Meissner Ph.D.	Scientific Co-Founder
Ms. Jolie M. Siegel J.D.	Executive VP, General Counsel & Secretary
Dr. Joseph McDonald Ph.D.	Chief Data Officer
Dr. Gary D. Glick Ph.D.	Founder, President, CEO & Director
Prof. Eicke Latz M.D., Ph.D.	Scientific Co-Founder
Dr. Kim Lewis Ph.D.	Scientific Co-Founder
Dr. Florian.I Schmidt Ph.D.	Scientific Co-Founder
Dr. Natalie Dales Ph.D.	Chief of Research Operations & Portfolio Strategy

FAQs

What is Odyssey Therapeutics Inc. share price today?

Odyssey Therapeutics Inc. share price today is $19.07 as on June 19, 2026 at 8:46 am IST at the close of the market. Odyssey Therapeutics Inc. share today touched a day high of $19.49 and a low of $17.95.

What is the 52 week high and 52 week low for Odyssey Therapeutics Inc. share?

Odyssey Therapeutics Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Odyssey Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $19.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Odyssey Therapeutics Inc.'s market capitalisation today?

Odyssey Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Odyssey Therapeutics Inc. Stock (ODTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Odyssey Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Odyssey Therapeutics Inc. Shares that will get you 0.0787 shares as per Odyssey Therapeutics Inc. share price of $19.07 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Odyssey Therapeutics Inc. Stock (ODTX) from India?

Indian investors can start investing in Odyssey Therapeutics Inc. (ODTX) shares with as little as ₹94.31 or $1 (as of June 22, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Odyssey Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 5:40 am IST). Based on Odyssey Therapeutics Inc. share’s latest price of $19.07 as on June 19, 2026 at 8:46 am IST, you will get 0.5244 shares of Odyssey Therapeutics Inc.. Learn more about fractional shares .